Henryk Zulewski

Henryk Zulewski

Auto-generated profile, based on publicly available information

Henryk Zulewski

Department of Biosystems Science and Engineering (D-BSSE) ETH Zurich, Zurich, Switzerland

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 April 2016 in Nature Communications
Verified
Journal Article
Open access
PSPratik Saxena
Pratik Saxena
BHBoon Chin Heng
Boon Chin Heng
PBPeng Bai
Peng Bai
MFMarc Folcher
Marc Folcher
HZHenryk Zulewski
Henryk Zulewski
MFMartin Fussenegger
Martin Fussenegger
Synthetic biology has advanced the design of standardized transcription control devices that programme cellular behaviour. By coupling synthetic signalling cascade- and transcription factor-based gene switches with reverse and differential sensitivity to the licensed food additive vanillic acid, we designed a synthetic lineage-control network combining vanillic acid-triggered mutually exclusive expression switches for the transcription factors Ngn3 (neurogenin 3; OFF-ON-OFF) and Pdx1 (pancreatic and duodenal homeobox 1; ON-OFF-ON) with the concomitant induction of MafA (V-maf musculoaponeurotic fibrosarcoma oncogene homologue A; OFF-ON). This designer network consisting of different network topologies orchestrating the timely control of transgenic and genomic Ngn3, Pdx1 and MafA variants is able to programme human induced pluripotent stem cells (hIPSCs)-derived pancreatic progenitor cells into glucose-sensitive insulin-secreting beta-like cells, whose glucose-stimulated insulin-release dynamics are comparable to human pancreatic islets. Synthetic lineage-control networks may provide the missing link to genetically programme somatic cells into autologous cell phenotypes for regenerative medicine.

11 May 2006 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
MEMichael Eberhardt
Michael Eberhardt
PSPatrick Salmon
Patrick Salmon
MMMarc-Alexander von Mach
Marc-Alexander von Mach
Jan G HengstlerJan G Hengstler
Jan G Hengstler
MBMarc Brulport
Marc Brulport
HZHenryk Zulewski
Henryk Zulewski

23 December 2004 in Stem Cells
Verified
Journal Article
Closed access
MMMarc‐Alexander von Mach
Marc‐Alexander von Mach
Jan G HengstlerJan G Hengstler
Jan G Hengstler
MBMarc Brulport
Marc Brulport
MEMichael Eberhardt
Michael Eberhardt
WSWiebke Schormann
Wiebke Schormann
HZHenryk Zulewski
Henryk Zulewski
Studies in rodents suggest the presence of a hepatopancreatic stem cell in adult pancreas that may give rise to liver cells in vivo. The aim of the present study was to determine the ability of human islet-derived cells to adopt a hepatic phenotype in vivo. Cultured human islet-derived progenitor cells that did not express albumin in vitro were stained with the red fluorescent dye PKH26 and injected into the liver of severe combined immunodeficiency mice. After 3 or 12 weeks, red fluorescent cells were detected in 11 of 15 livers and were mostly single cells that were well integrated into the liver tissue. Human albumin was found in 8 of 11 animals by immunohistochemistry, and human albumin mRNA was detected in 4 of 10 host livers. The mechanism underlying this phenomenon seems to be transdifferentiation, because human and mouse albumin were found to be expressed in distinct cells in the host liver

1 July 2013 in Diabetes Research and Clinical Practice
Verified
Journal Article
Closed access
AMAnna Elisabeth Minder
Anna Elisabeth Minder
DADominique Albrecht
Dominique Albrecht
JSJuliane Schäfer
Juliane Schäfer
HZHenryk Zulewski
Henryk Zulewski

5 February 2011 in Diabetic Medicine
Verified
Journal Article
Closed access
PDF file
DAD. Albrecht
D. Albrecht
JPJardena Puder
Jardena Puder
UKU. Keller
U. Keller
HZH. Zulewski
H. Zulewski